Common Stock, Shares, Issued of OCULAR THERAPEUTIX, INC from Q4 2013 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
OCULAR THERAPEUTIX, INC quarterly Common Stock, Shares, Issued history and change rate from Q4 2013 to Q3 2025.
  • OCULAR THERAPEUTIX, INC Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 175M shares, a 11.7% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

OCULAR THERAPEUTIX, INC Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 175M +18.3M +11.7% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 173M +17.3M +11.1% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 159M +4.56M +2.95% 31 Mar 2025 10-Q 05 May 2025
Q4 2024 158M +42.8M +37.2% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 157M +77.2M +97.3% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 156M +76.4M +96.4% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 155M +77.2M +99.6% 31 Mar 2024 10-Q 07 May 2024
Q4 2023 115M +37.8M +48.9% 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 79.4M +2.4M +3.12% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 79.2M +2.32M +3.02% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 77.5M +757K +0.99% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 77.2M +470K +0.61% 31 Dec 2022 10-K 11 Mar 2024
Q3 2022 77M +403K +0.53% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 76.9M +455K +0.6% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 76.8M +523K +0.69% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 76.7M +735K +0.97% 31 Dec 2021 10-K 06 Mar 2023
Q3 2021 76.6M +13.5M +21.5% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 76.5M +13.5M +21.4% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 76.2M +23.2M +43.7% 31 Mar 2021 10-Q 05 May 2021
Q4 2020 76M +25.7M +51% 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 63.1M +15M +31.2% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 63M +18.9M +42.7% 30 Jun 2020 10-Q 07 Aug 2020
Q1 2020 53M +10.2M +23.8% 31 Mar 2020 10-Q 08 May 2020
Q4 2019 50.3M +8.82M +21.2% 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 48.1M +7.56M +18.6% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 44.1M +5.62M +14.6% 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 42.8M +5.56M +14.9% 31 Mar 2019 10-Q 10 May 2019
Q4 2018 41.5M +11.9M +40% 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 40.5M +11.1M +37.9% 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 38.5M +9.42M +32.4% 30 Jun 2018 10-Q 07 Aug 2018
Q1 2018 37.3M +8.35M +28.8% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 29.7M +4.63M +18.5% 31 Dec 2017 10-K 07 Mar 2019
Q3 2017 29.4M +4.51M +18.1% 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 29.1M +4.23M +17.1% 30 Jun 2017 10-Q 08 Aug 2017
Q1 2017 28.9M +4.18M +16.9% 31 Mar 2017 10-Q 05 May 2017
Q4 2016 25M +274K +1.11% 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 24.9M +150K +0.61% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 24.8M +102K +0.41% 30 Jun 2016 10-Q 09 Aug 2016
Q1 2016 24.8M +3.33M +15.5% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 24.8M +3.42M +16% 31 Dec 2015 10-K 10 Mar 2017
Q3 2015 24.7M +3.41M +16% 30 Sep 2015 10-Q 10 Nov 2015
Q2 2015 24.7M +21.6M +690% 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 21.4M 31 Mar 2015 10-Q 15 May 2015
Q4 2014 21.3M +18.7M +697% 31 Dec 2014 10-K 10 Mar 2016
Q3 2014 21.3M 30 Sep 2014 10-Q 12 Nov 2014
Q2 2014 3.13M 30 Jun 2014 10-Q 29 Aug 2014
Q4 2013 2.68M 31 Dec 2013 10-K 20 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.